Clinical Trial Update: Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia [Phase 3]

View source ↗

Summary

Phase 3 pediatric insomnia trial evaluating tasimelteon versus placebo is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Tasimelteon (tasimelteon)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Insomnia Disorder | Phase 3 | Status: RECRUITING